Cerebral glucose metabolism in neurofibromatosis type 1 assessed with [18F]-2-fluoro-2-deoxy-D-glucose and PET.

Cerebral PET with [18F]-2-fluoro-2-deoxy-D-glucose has been performed in four patients with neurofibromatosis type 1 (NF1) to assess the relation between cerebral metabolic activity, MRI, and the presence of neurological symptoms, including seizures, as well as mental and language retardation. Wides...

Full description

Saved in:

Bibliographic Details
Main Authors:	Balestri, P, Lucignani, G, Fois, A, Magliani, L, Calistri, L, Grana, C, Di Bartolo, R M, Perani, D, Fazio, F
Format:	Artigo
Language:	Inglês
Published:	1994
Subjects:	Research Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC1073228/ https://ncbi.nlm.nih.gov/pubmed/7798976
Tags:	Add Tag No Tags, Be the first to tag this record!

Cerebral glucose metabolism in neurofibromatosis type 1 assessed with [18F]-2-fluoro-2-deoxy-D-glucose and PET.

Similar Items